Chemotech Industries India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 35.92%
- Profit Growth -38.02%
- Ebitda -18.12%
- Net Worth 50.44%
- Total Assets 126.58%
About Chemotech Industries India
Chemotech Industries India Private Limited (CIIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 September 2020 (Four years and four months 2 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suhas Sakalkar and Ketakee Durve serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290MH2020PTC346978
- Company No.
346978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Chemotech Industries India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suhas Sakalkar  | Director | 30-Sep-2020 | Current |
| Ketakee Durve | Director | 28-Oct-2022 | Current |
Financial Performance of Chemotech Industries India.
Chemotech Industries India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.92% increase. The company also saw a substantial fall in profitability, with a 38.02% decrease in profit. The company's net worth Soared by an impressive increase of 50.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemotech Industries India?
Unlock access to Chemotech Industries India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemotech Industries India?
Chemotech Industries India has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemotech Industries India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemotech Industries India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
